Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
doi:10.1378/chest.06-2273
(Chest. 2007; 131:1133-1141)
© 2007 American College of Chest Physicians
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, J.
Right arrow Articles by Qin, X.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, J.
Right arrow Articles by Qin, X.-J.

Diagnostic Value of Interferon-{gamma} in Tuberculous Pleurisy*

A Metaanalysis

Jing Jiang, MD; Huan-Zhong Shi, MD, PhD; Qiu-Li Liang, MD; Shou-Ming Qin, MD and Xue-Jun Qin, MD

* From the Institute of Respiratory Diseases, First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, People’s Republic of China.

Correspondence to: Huan-Zhong Shi, MD, Institute of Respiratory Diseases, First Affiliated Hospital, Guangxi Medical University, Nanning 530021, Guangxi, People’s Republic of China; e-mail: hzshi{at}vip.tom.com

Abstract

Background: Conventional tests are not always helpful in making a diagnosis of tuberculous pleurisy. Many studies have investigated the usefulness of interferon (IFN)-{gamma} measurements in pleural fluid for the early diagnosis of tuberculous pleurisy. We conducted a metaanalysis to determine the accuracy of IFN-{gamma} measurements in the diagnosis of tuberculous pleurisy.

Methods: After a systematic review of English-language studies, sensitivity, specificity, and other measures of accuracy of IFN-{gamma} concentrations in the diagnosis of pleural effusion were pooled using random-effects models. Summary receiver operating characteristic curves were used to summarize overall test performance.

Results: Twenty-two studies met our inclusion criteria. The summary estimates for IFN-{gamma} in the diagnosis of tuberculous pleurisy in the studies included were as follows: sensitivity, 0.89 (95% confidence interval [CI], 0.87 to 0.91); specificity, 0.97 (95% CI, 0.96 to 0.98); positive likelihood ratio, 23.45 (95% CI, 17.31 to 31.78); negative likelihood ratio, 0.11 (95% CI, 0.07 to 0.16); and diagnostic odds ratio, 272.7 (95% CI, 147.5 to 504.2).

Conclusions: IFN-{gamma} determination is a sensitive and specific test for the diagnosis of tuberculous pleurisy. The measurement of IFN-{gamma} levels in pleural effusions is thus likely to be a useful tool for diagnosing tuberculous pleurisy. The results of IFN-{gamma} assays should be interpreted in parallel with clinical findings and the results of conventional tests.

Key Words: interferon • pleural effusion • tuberculosis







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American College of Chest Physicians.